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Abstract
BACKGROUND: Granulysin, a cytotoxic protein expressed in human natural killer cells and activated
T lymphocytes, exhibits cytolytic activity against a variety of intracellular microbes. Expression and
transcription have been partially characterised in vitro and four transcripts (NKG5, 519, 520, and 522)
were identified. However, only a single protein product of 15 kDa was found, which is subsequently
processed to an active 9 kDa protein. RESULTS: In this study we investigated generation of granulysin
in lymphokine activated killer (LAK) cells and antigen (Listeria) specific T-cells. Semiquantitative
RT-PCR revealed NKG5 to be the most prominent transcript. It was found to be up-regulated in a
time-dependent manner in LAK cells and antigen specific T-cells and their subsets. Two isoforms of
519 mRNA were up-regulated under IL-2 and antigen stimulation. Moreover, two novel transcripts,
without any known function, comprising solely parts of the 5 prime region of the primary transcript,
were detected. A significant increase of granulysin expressing LAK cells as well as antigen specific
T-cells was shown by fluorescence microscopy. On the subset level, increase in CD4+ granulysin
expressing cells was found only under antigen stimulation.Immunoblotting showed the 15 kDa form of
granulysin to be present in the first week of stimulation either with IL-2 or with bacterial antigen.
Substantial processing to the 9 kDa form was detected during the first week in LAK cells and in the
second week in antigen specific T-cells. CONCLUSION: This first comprehensive study of granulysin
gene regulation in primary cultured human lymphocytes shows that the regulation of granulysin
synthesis in response to IL-2 or bacterial antigen stimulation occurs at several levels: RNA expression,
extensive alternative splicing and posttranslational processing.
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Abstract
Background: Granulysin, a cytotoxic protein expressed in human natural killer cells and activated
T lymphocytes, exhibits cytolytic activity against a variety of intracellular microbes. Expression and
transcription have been partially characterised in vitro and four transcripts (NKG5, 519, 520, and
522) were identified. However, only a single protein product of 15 kDa was found, which is
subsequently processed to an active 9 kDa protein.
Results: In this study we investigated generation of granulysin in lymphokine activated killer (LAK)
cells and antigen (Listeria) specific T-cells. Semiquantitative RT-PCR revealed NKG5 to be the most
prominent transcript. It was found to be up-regulated in a time-dependent manner in LAK cells and
antigen specific T-cells and their subsets. Two isoforms of 519 mRNA were up-regulated under IL-
2 and antigen stimulation. Moreover, two novel transcripts, without any known function,
comprising solely parts of the 5 prime region of the primary transcript, were detected. A significant
increase of granulysin expressing LAK cells as well as antigen specific T-cells was shown by
fluorescence microscopy. On the subset level, increase in CD4+ granulysin expressing cells was
found only under antigen stimulation.
Immunoblotting showed the 15 kDa form of granulysin to be present in the first week of
stimulation either with IL-2 or with bacterial antigen. Substantial processing to the 9 kDa form was
detected during the first week in LAK cells and in the second week in antigen specific T-cells.
Conclusion: This first comprehensive study of granulysin gene regulation in primary cultured
human lymphocytes shows that the regulation of granulysin synthesis in response to IL-2 or
bacterial antigen stimulation occurs at several levels: RNA expression, extensive alternative splicing
and posttranslational processing.
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A crucial role in destroying tumor cells, virus infected cells
and intracellular pathogens is played by natural killer cells
(NK) cells and cytotoxic T lymphocytes (CTL) [1-3]. They
are armed with cytotoxic granules containing various
effector molecules such as granulysin, perforin, and sev-
eral granzymes [4,5]. Granulysin, an antimicrobial pro-
tein, was first identified by a subtractive hybridization
procedure in functional T cell lines and alloantigen and
mitogen stimulated PBL and was initially referred to as
519 [6]. A similar gene product, referred to as NKG5, was
found in the NK cell line EDF as well as in different T cell
lines and clones [7]. Furthermore, Manning et al. [8]
investigated the structure and transcription of the granu-
lysin gene in the functional T cell line AJY and found the
alternative spliced transcripts 519, 520, and 522 but no
NKG5.
The granulysin gene is located on the human chromo-
some 2 [9] and comprises 6 exons within a 3.9 kb
genomic locus encoding at least four alternatively spliced
transcripts (NKG5, 519, 520 and 522), all differing mostly
in exon 2. The most abundant transcript in AJY was iden-
tified to be 520 appearing late after T cell activation [8].
Since 520 has an appropriate Kozak sequence for the ini-
tiation of translation, this transcript was thought to be
responsible for the majority of granulysin protein pro-
duced [5]. NKG5, which is very similar to 520, but is
absent in the AJY, would have the same function in NK
cells.
Granulysin is expressed as a 15 kDa protein which is proc-
essed by proteolytic cleavage at both N and C termini of
the 15 kDa precursor to the active 9 kDa form [10].
Whereas the 15 kDa protein is produced rapidly, has a
shorter half-life and is poorly secreted, the secretory 9 kDa
form is produced slowly and is relatively stable [5].
Recombinant 9 kDa granulysin exhibits cytolytic activity
against microbial and tumor targets [3,11,12].
Overall, the complex transcriptional activity of the granu-
lysin gene was found by studying different cell lines but a
comprehensive analysis of the granulysin expression in
primary cultured lymphocytes has not been performed. It
has been shown that granulysin expression is induced in
different lymphocyte subsets in response to bacterial anti-
gens [13-15].
In this study, we examined the expression and processing
of granulysin in non-transformed lymphocytes which
were either stimulated with r-IL-2 (lymphokine activated
killer cells LAK cells) or primed by autologous dendritic
cells (DC). We used two different bacterial antigens, Liste-
ria innocua and Listeria monocytogenes, which are presented
to the immune system in different ways While L. innocua
is Gram-positive, non pathogenic, ubiquitous bacterium,
which may be processed and presented via the MHC class
II pathway, L. monocytogenes is an intracellular pathogen,
which can enter the cytosol of infected host cell allowing
processing for presentation on MHC class I molecules [16-
18]. Both Listeria species have been found to be success-
fully killed by granulysin [11,12].
Results
Transcriptional regulation of granulysin in LAK cells
Transcriptional analysis of the granulysin expression has
been assessed in cell lines but not in primary cultured
lymphocytes. To address this issue we investigated the
transcripts encoded by the granulysin gene in freshly iso-
lated PBMC stimulated with IL-2 for 2 weeks.
LAK cells showed high expression of NKG5, of two iso-
forms of 519 mRNA and two novel transcripts (Fig. 2A).
Regarding the transcripts published by Manning et al. [8]
two sense primers in exon 1 (primer 2 and 3 (Fig. 1)) were
tested but failed to expand the mRNAs corresponding to
520 or 522 (data not shown). However, all tested sense
primers in exon 1 (primer 1, 2, 3, 4 (Fig. 1)) and a reverse
primer in exon 5 (primer 7) resulted in a single PCR prod-
uct (Fig. 2A) that was identified by sequencing as the pub-
lished transcript variant NKG5 (GenBank NM 006433).
Both products obtained with the 519 primer (primer 5
(Fig. 1)) were also sequenced and identified to be similar
to the 519 transcript published by Manning et al. [8]. Both
isoforms differ from the published transcript of 519 by
not containing any part of exon 1 (transcripts are called
519i throughout this paper) and one isoform additionally
lacks 81 nucleotides at the 3' end of exon 2 (519is, see Fig.
1).
To investigate whether any transcript includes exons 1 and
2, we performed a RT-PCR using the NKG5 sense B
(primer 2) and an antisense primer in exon 2 (primer 6).
By this approach two novel short transcripts (ST) were
found in LAK cells and in all subsets (Fig. 2A, arrows p38,
p25). Sequence analysis revealed ST p25 to comprise exon
1 and exon 2 (see Fig. 1) and ST p38, comprised of p25
plus the whole intron 1, as published by Manning et al.
[8]. None of the ST extended to exon 3 (data not shown).
Since both ST contain a Kozak consensus translation initi-
ation site, they could be translated into peptides with a
length of 25 and 38 amino acids, respectively. The middle
band that appears on the agarose gel (Fig. 2A) is the
hybridization product of the two ST, with loop formation
within intron 1. This was proven by 15 repeated denatur-
ation and annealing steps of the extracted middle band
resulting again in 3 bands (data not shown).
Semi-quantitative analysis of the PCR products revealed
that in the total population of LAK cells, the NKG5 mes-Page 2 of 12
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to day 15 (p = 0.019), while the two variants of 519
increased by a factor 8.8 (519i; p = 0.002) and 4.4 (519is;
p = 0.007), respectively (Fig. 2B).
The ST did not show an apparent IL-2 dependency. Since
each donor exhibited a different regulation pattern, a clear
tendency for up- or down regulation in response to IL-2
could not be determined (Fig. 2B).
Next, we examined the expression of the various longer
transcripts in T cell subsets. Using magnetic beads, CD4+,
CD8+ and CD56+ cells were isolated at days 4 and 15 of
continuous IL-2 stimulation and RT-PCR analysis was per-
formed. As shown in Figure 2C the highest expressed tran-
script in all subsets at day 4 is NKG5, while the 519
isoforms are poorly expressed, especially in CD4+ cells.
During continuous IL-2 stimulation all transcripts ana-
lyzed were at least slightly upregulated in the different cell
subsets in all donors tested (Fig. 2C, one representative
donor shown).
Short transcripts were also detected in all subsets at days 4
and 15, but their kinetics of expression were not evaluated
(data not shown).
Transcriptional regulation of granulysin in antigen specific 
T-cells
Host defense mechanisms against intracellular microbes
require induction of effector molecules such as granulysin
during infection. Therefore, we investigated if granulysin
gene expression is induced upon antigen driven stimula-
tion of T cells and if so which of the different granulysin
transcripts might be involved. L. innocua and L. monocy-
Schematic view of known and found granulysin transcriptsFigure 1
Schematic view of known and found granulysin transcripts. Upper part of the figure shows schematically transcripts 
from GenBank and down part transcripts that were found in LAK or antigen specific T-cells. Black boxes indicate coding and 
gray boxes noncoding exon parts. Exons are marked with roman numbers. Dotted lines correspond to intron regions. Arabic 
numbers 1 to 7 stay for primers numbered in the same way as in Table 1.Page 3 of 12
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The expression of granulysin transcripts was investigated
in antigen specific T-cells from autologous MLCs by RT-
PCR. The identical mRNAs found in LAK cells were
detected in the T-cells stimulated with L. innocua or L.
monocytogenes, including the ST (data not shown). Semi-
quantitative analysis of the transcripts (Fig. 3) revealed
that NKG5 mRNA showed the highest basal expression at
day 0 and was upregulated between days 0 and 12 by an
average factor of 1.7 (L. innocua, x1.68, p = 0.02; L. mono-
cytogenes, x1.7, p = 0.002). Both 519 isoforms showed a
more prominent increase between day 0 and day 12 of
stimulation by an average factor of 3.8 (519i) and 2.7
(519is), respectively (L. innocua, x4 519i, p = 0.004 and
x2.7 519is p = 0.006; L monocytogenes, x3.6 519i, p =
0.0004 and x2.8 for 519is p = 0.01). In L. innocua specific
T cells 519 isoforms were continuously increasing during
the whole period of antigen stimulation in contrast to L.
monocytogenes specific T cells where the increase was rapid
in the first weak of stimulation but remained unchanged
during the second weak. Semi-quantitative analysis of
short transcripts did not allow us to see any tendency for
up- or down-regulation under bacterial stimulation. OVA
specific T cells maintained basal expression levels of
NKG5 mRNA during the stimulation period, with no
upregulation. The two 519 isoforms remained at very low
Granulysin gene expression in LAK cells and different subpopulationsFigure 2
Granulysin gene expression in LAK cells and different subpopulations. LAK cells were cultivated within 2 weeks 
under continuous IL-2 stimulation. At indicated time points cell samples were taken for RT-PCR analysis. Representative gel 
image shows transcripts present in LAK cells over the stimulation period (A). The same transcripts were found in different 
subpopulations (not shown). Graph (B) represents results of semiquantitative analysis of the transcripts normalized to actin 
(gel image, lines A) in LAK cells from three different donors. Each symbol represents one donor and bars correspond to the 
mean value. Graph (C) shows the same analysis in different subpopulations where one representative donor is shown.Page 4 of 12
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Short transcripts showed a slight increase, which was sta-
tistically significant (p25, p = 0.039; p38, P = 0.029).
None of the transcripts were upregulated in T cells where
MOCK treated DCs were used in MLC.
In T cell subsets all transcripts, but especially the 519 iso-
forms showed prominent upregulation between day 0
and 6. Between day 6 and day 12 no significant difference
in the mRNA levels was found (data not shown). Overall
these data indicate that especially the two 519 isoforms
seem to be tightly regulated on transcriptional level in
response to either antigen or IL-2 stimulation
Granulysin expression in LAK cells
To follow the granulysin expression under continuous IL-
2 stimulation, LAK cells were stained for granulysin at
indicated time points and analyzed by counting granu-
lysin positive cells. The expression of granulysin within
the whole LAK population was not changed after 4 days
but a significant increase became apparent after 8 and 15
days of IL-2 stimulation (Fig. 4A). Granulysin expression
in different subsets of LAK cells was investigated by dou-
ble labeling for CD surface markers and granulysin fol-
lowed by counting of at least 500 cells. Significant
increase in granulysin expression could only been seen in
CD8+ cells from day 4 to day 15, while CD56+ cells
Granulysin gene expression in antigen specific T-cellsFigure 3
Granulysin gene expression in antigen specific T-cells. L. innocua (A) respectively L. monocytogenes (B) OVA (C) and 
MOCK (D) specific T-cells were cultivated as described in Materials and methods. Samples were collected before stimulation 
(day 0), before restimulation (day 6) and 6 days after restimulation (day 12). PCR was performed and analysed by gel electro-
phoresis. Values are results from semiquantitative analysis of transcripts normalised to actin from the same cDNA. Each sym-
bol represents one donor.Page 5 of 12
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and no significant alteration was observed until day 15
(Fig. 4B). Only a few CD4+ cells were found to be positive
for granulysin over the whole period of stimulation. The
phenotypic analysis of LAK cells revealed that especially
the number of CD56+ and the CD8+ cells increased, while
the CD4+ cells decreased over time (Fig. 4C). The pheno-
typic pattern of LAK cells under IL-2 stimulation varied
between the different donors. This is consistent with
former results obtained by phenotyping PBMC of differ-
ent donors under IL-2 stimulation [19]. But as a trend in
most of the donors the number of CD56+ and CD8+ cells
was rising while the number of CD4+ cells was decreasing
over time.
These data indicate that in LAK cells the increase in gran-
ulysin expression is mostly due to the increasing number
and expression level in CD8+ cells as well as the increasing
number of CD56+ cells during IL-2 stimulation.
The spatial pattern of the granulysin distribution in LAK
cells was examined by immunostaining for granulysin
using a polyclonal anti-granulysin Ab, which allows the
detection of the 15 kDa and 9 kDa form of granulysin.
Confocal microscopy analysis at day 15 of stimulation
revealed a vesicular staining pattern in highly polarized
cells consistent with the granular localization of granu-
lysin (Fig. 5A).
Expression of granulysin in antigen specific T-cells
To determine the regulation of granulysin expression
upon bacterial antigen stimulation, antigen specific T cells
were stained with anti-granulysin Ab at days 0, 6 and 12.
The percentage of granulysin positive cells was deter-
mined by counting at least 300 cells. Granulysin expres-
sion was induced after 6 and 12 days from 18% to around
50% granulysin positive cells in response to both bacterial
antigens. Cells stimulated with OVA or MOCK did not
show any increase in granulysin expression over time (Fig.
6A).
The T cell population consisted mostly of CD4+ and CD8+
cells with only moderate changes over time as assessed by
flow cytometry (Fig. 6B and 6C).
Analysis of granulysin expression in different subpopula-
tions was done in CD4+ and CD8+ cells separated at day 6
and day 12 and stained for granulysin. In contrast to IL-2
stimulated LAK cells, in L. innocua as well as in L. monocy-
togenes specific T cells, around 30% CD4+ cells expressed
granulysin. Approximately 40% of the CD8+ cells
expressed granulysin at day 12 under these conditions
(Fig. 6D and 6E). There was a very similar pattern of
expression in different subpopulations in the differently
primed T cells allowing no conclusion on the preferential
Time dependent expression of granulysin in LAK cells and different subpopulation  F gure 4
Time dependent expression of granulysin in LAK 
cells and different subpopulations. LAK cells (A) or dif-
ferent subpopulations (B) were stained for granulysin and CD 
surface markers. Cells were analysed using confocal laser 
scanning microscope by counting 500 cells pro sample. 
Graph (C) represents phenotype analysis of LAK cells. Four 
different donors were analysed and each symbol represents 
one donor. Bars indicate mean values. (* p < 0.05; * * p < 
0.005; * * * p < 0.0005)Page 6 of 12
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ent in the graphs there was a higher scattering in the gran-
ulysin expression in subsets of cells after antigen specific
stimulation compared to LAK cells. This reflects the obser-
vation that the T cells of some of the donors were highly
responsive to Listeria antigens while others showed only a
slight increase in granulysin expression.
High resolution imaging of Listeria-specific T cells after
granulysin immunostaining revealed a granular and
slightly polarized pattern of granulysin in round shaped
cells that are smaller in size compared to LAK cells (Fig. 5B
and 5C).
Processing of granulysin in LAK cells and antigen specific 
T-cells
Pena et al. [3] showed granulysin to be expressed as 15
kDa and 9 kDa forms in CTL cell lines, late after activation
with alloantigen. To investigate which protein forms are
induced upon IL-2 stimulation, LAK cells were analyzed at
indicated time points using Western blot analysis. In
unstimulated cells only the 15 kDa protein was detecta-
ble. During the IL-2 stimulation the 15 kDa precursor
became more prominent while the active 9 kDa form was
first visible after 4 days of stimulation. In the second week
of stimulation the signal of the 15 kDa protein dimin-
ished and a strong 9 kDa band was detected (Fig. 7A). This
was compared to the kinetics of protein processing under
antigen stimulation. As shown in Figure 7BListeria specific
T-cells accumulated the 15 kDa precursor during the
whole period of stimulation while the 9 kDa protein was
first detected in the second week of stimulation.
Discussion
Activation of T-cells and NK cells can occur through a
wide range of stimuli, including bacterial, tumour and
viral antigens or cytokines. As a result, these cells express
a number of different cytotoxic proteins such as perforin
or granzymes to kill target cells or granulysin for killing
intracellular bacteria [6,20-23]. The expression and regu-
lation of granulysin has so far only been studied in cell
lines of NK and T-cell origin [8], where the transcripts
NKG5, 520, 522 and 519 have been found. To a limited
extent, 519 expression in response to mitogen and alloan-
tigen stimulation was also studied in PBMC [6]. NKG5
was found only in a NK cell line [8] and was therefore
thought to be a NK specific transcript. Transcripts 519,
520 and 522 had been found in AJY, a functional T-cell
line [8]. Our newly described variants of 519 as well as the
novel short transcripts were not found to be expressed in
AJY. On the other side, we could not detect 522 and 520
mRNAs described in AJY. In our system all transcripts
detected were expressed both in NK and T-cells. Another
striking difference between transcript 519, found in the
cell line AJY, and the 519 isoforms in PBMC derived LAK
and Listeria specific T-cells, is the absence of exon 1. Cur-
rently, it can only be speculated if all these differences are
due to a different regulation of granulysin gene expression
in primary cultured cells. Of longer transcripts, the consti-
tutively expressed NKG5 mRNA has an appropriate Kozak
consensus sequence and a putative hydrophobic leader
cleavage site and, as we found, it is also expressed in T-
cells. It is most likely the transcript encoding the 15 kDa
protein form that is then processed to the active 9 kDa
secreted protein in NK and T-cells. In contrast to the
NKG5 transcript, the two 519 isoform mRNAs had a very
low basal expression and were significantly and strictly
upregulated by IL-2 and bacterial antigen, indicating pos-
sible contribution of these alternative spliced transcripts
Confocal microscopy of LAK and Listeria specific T cells labeled for granulysinFigure 5
Confocal microscopy of LAK and Listeria specific T 
cells labeled for granulysin. LAK cells (A) after 15 days of 
IL-2 stimulation, L. innocua (B) as well as L. monocytogenes spe-
cific T cells (C) after 12 days culture. Bar 10 μm.Page 7 of 12
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The longer form of the 519 isoform has also one potential
in-frame initiation codon but it lacks the Kozak consensus
as well as a hydrophobic leader sequence which would
suggest that little or no secreted protein is encoded by this
transcript. It has indeed been shown that transient expres-
sion of 519 cDNA in COS-7 cells did not produce a detect-
able level of protein [5]. As the 519 short variant does not
have an in-frame start codon, its possible impact is rather
unclear. The short transcripts (p25 and p38) have the
potential to be translated since they could use the same
start codon as NKG5 and could enter the secretory path-
way, but no experimental evidence is yet available.
As experimental evidence is still missing, we can only
speculate how the transcriptional regulation of granulysin
gene expression is mediated. The granulysin gene shows
extensive alternative splicing which is in contrast to other
cytotoxic proteins, such as perforin and granzyme B
encoded by only one transcript [6,24,25]. For the vast
majority of alternative splicing events, the functional sig-
nificance is unknown. The potential role of alternative
splicing and different protein isoforms in the regulation
of transcriptional activity has already been reported in
humans e.g. for p53 and GLI2 proteins [26,27]. Willing-
ham et al. found several functional non coding RNAs.
Some of them are essential for cell viability, one repressor
of Hedgehog signaling and one that acts as repressor of
transcription factor NFAT, which is itself required for T-
cell receptor-mediated immune response [28]. Some pos-
sible functions of non-coding transcripts could be stabiliz-
ing of coding transcript or post-transcriptional regulation
of gene expression [29,30]. To find out whether the two
novel transcripts (p38 and p25) are translated in CTLs,
their possible roles and the function of the 519 isoforms
needs further investigations.
It has been reported that primary human NK cells consti-
tutively express granulysin whereas CD8+ cells express
granulysin upon stimulation [31-33]. Our results revealed
Expression of granulysin over time in antigen specific T cells and different subsetsFigure 6
Expression of granulysin over time in antigen specific T cells and different subsets. T-cells were removed from 
mixed lymphocyte culture at selected time points and stained with anti-granulysin Ab. Cells were analysed with a confocal laser 
scanning microscope counting 300 cells. Graph (A) shows granulysin expression in antigen specific T-cells as a whole popula-
tion; (B) represent phenotype of L. innocua specific T cells; (C) phenotype of L. monocytogenes specific T cells graph (D) repre-
sent granulysin expression in different subsets in L. innocua specific T cells and graph (E) in L. monocytogenes specific T cells. In 
(B), (C), (D), and (E) every donor is indicated with one symbol. Bars are mean values. (*** p < 0.0005)Page 8 of 12
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2 or antigen stimulation observed in the whole cell popu-
lation Monitoring different subpopulations, IL-2
increased protein synthesis only in CD8+cells. Recently
Zheng et al. [34] showed that IL-2 induces granulysin
expression in isolated CD4+ cells. In our system, IL-2 did
not induce upregulation of granulysin expression in CD4+
cells, but all transcripts were induced in a time dependent
manner. Approximately 10–15% CD4+ cells expressed
granulysin between the first and second week of IL-2 stim-
ulation. This discrepancy could be due to the fact that we
did not isolate CD4+ out of the whole population prior to
stimulation. Similar to our results, Liu et al. showed that
IL-2 induced expression of perforin and granzyme A and
B was mostly seen in CD8+ subset, but in CD4+ cells they
also detected only mRNA [20,35]. As expected, the CD56+
population showed very high constitutive expression of
granulysin protein and messenger. When stimulated with
IL-2, CD56+ cells proliferate and after 2 weeks constitute
around a half of the whole LAK cell population [19].
Taken together, increased levels of granulysin under IL-2
stimulation, monitored in the whole LAK population is
due to an increasing number of CD56+ and CD8+ cells as
well as due to the induction of the protein synthesis in
CD8+ cells. The number of CD4+ cells decreased under IL-
2 stimulation, which could be explained by different
expression of IL-2 receptor chains in different T cell sub-
sets [20,36,37].
A slightly different pattern was observed in T cells specific
for L. innocua or L. monocytogenes, where stimulation with
both bacterial antigens revealed a similar phenotype with
almost equal proliferation of CD4+ and CD8+ cells. This is
in agreement with other studies showing that Listeria anti-
gens may be presented via MHC class I and class II mole-
cules [38-40]. Similar to IL-2 stimulation, the increase in
granulysin expression in the whole population was signif-
icant over time. In contrast, the percentage of granulysin-
expressing cells was rising in both the CD4+ and the CD8+
populations. On mRNA levels after bacterial or cytokine
stimulation all transcripts except NKG5 were upregulated
between day 0 and 6 after which a plateau was reached
(data not shown). This would mean that granulysin avail-
ability is delayed after T-cell activation, but supplies are
replenished during Ag-specific responses.
Our results confirmed a rather slow kinetic of granulysin
production similar to those described for other proteins
associated with T cell terminal differentiation such as
granzyme and perforin [41,42]. Studying the kinetics of
protein processing proved that IL-2 stimulation leads to
processing of granulysin to an active 9 kDa form already
in the first week, which is in correlation with data shown
by Zheng et al. 2007 where granulysin was detected by day
5, whereas processing under bacterial stimulation occures
during the second week of stimulation.
Conclusion
This first comprehensive study reveals various levels of
granulysin gene regulation in human primary lym-
phocytes under different stimuli. It shows a complex tran-
scriptional expression pattern encoding different mRNA
variants through use of alternative splicing, followed by
cell type specific translational regulation and slow post-
translational processing.
Methods
Generation of LAK cells and dendritic cells (DC)
Human DC and LAK cells were generated in vitro from
blood-derived precursors as already described [43].
Briefly, human peripheral blood monocytes (PBMC)
obtained from venous blood of healthy volunteers were
isolated by Ficoll-Paque (Pharmacia Biotech, Uppsala,
Sweden) density centrifugation. The PBMC were cultured
in RPMI 1640 supplemented with penicillin/streptomy-
cin and 10% human serum (HS) for 2 hours. To obtain
dendritic cells (DC), the adherent cells were cultured for 6
days in RPMI 1640 supplemented with penicillin/strepto-
mycin, 5% HS (DC culture medium), recombinant
human granulocyte monocyte colony-stimulating factor
(rhGM-CSF, 50 ng/ml, Novartis, Basel, Switzerland) and
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Kinetic of granulysin processing in LAK and Listeria 
specific T cells. LAK (A) or antigen specific T cells (B) were 
taken out of culture at indicated time points followed by lysis 
of cells and separation of proteins by SDS-PAGE. Proteins 
were blotted and detected using anti-granulysin Ab (1:1000). 
The blot was stripped and probed for the β-actin.Page 9 of 12
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The non-adherent cells were cultured in RPMI 1640 sup-
plemented with penicillin/streptomycin (Life Technolo-
gies, Paisley, UK), 5% heat-inactivated pooled human A
serum (HS, Blood Bank SRK Zürich, Switzerland), and IL-
2 (66 U/ml, R&D Systems, Abingdon, UK). On days 0, 4
and 15, phenotypic characterization of the LAK cells was
performed by flow cytometry using anti-human CD Abs
(see below). On days 4 and 15, different T-cell subpopu-
lations were positively selected by anti-CD4, anti-CD8
and anti-CD56 MicroBeads using Octomacs (Miltenyi
Biotec, Bergisch-Gladbach, Germany). Cell purity was
more than 90% as assessed by flow cytometry.
Generation of antigen specific T-lymphocytes, autologous 
mixed leukocyte-DC culture (MLC)
DC were Listeria challenged as described previously
[16,16,16,44,43,42,41,41] Briefly, 6 days matured DC
cells were transferred to 6-well plates and challenged with
opsonized L. innocua or L. monocytogenes at a multiplicity
of infection (MOI) of 10 or Ovalbumin 5 μg/ml for 1 hour
at 37°C. Non-internalized bacteria and OVA were
removed by washing with PBS before adding media con-
taining 20 μg/ml gentamycin (Sigma, St. Louis, MO). DC
washed with equivalent amount of PBS served as a nega-
tive control (MOCK). After 16 hours, freshly isolated
autologous, nonadherent PBMC in RPMI with 5% HS
were added to the challenged DC at the PBMC/DC ratio of
10/1. The MLC was cultured for 6 days before restimula-
tion with fresh Listeria challenged autologous DC. At days
0, 6 and 12 flow cytometry phenotypic analysis of the
antigen specific T-cells was performed using anti-human
CD Abs (see below). Additionally, at day 6 and day 12,
CD4+ and CD8+ cells were separated using MACS beads.
Flow cytometry
For the phenotyping of the PBMC the following Abs were
used according the manufacturers instructions: FITC-
labeled anti-human CD4, PE-coupled anti-human CD8,
FITC-labeled anti-human CD3, PE-coupled anti-human
CD56, (all Diatec.Com AS, Oslo, Norway). Cells were
analyzed in FC500 flow cytometer (Beckman Coulter,
Fullerton, CA) using CXP software (Beckman Coulter).
Confocal laser scanning microscopy
T-cells or LAK cells were fixed with 1.5% formaldehyde
and 1% sucrose in PBS and were cytospun onto glass
slides and permeabilized with 0.1% Triton X-100 (Sigma)
in PBS for 40 seconds at room temperature. Unspecific
binding was blocked with 0.5% BSA (bovine serum albu-
min, Fluka, Buchs, Switzerland) in PBS for 30 minutes at
room temperature. The samples were labeled with guinea
pig anti-granulysin antiserum generated in our laboratory
as described by Walch et al. [11]. Omitting the first Abs
served as control for specificity. For detection FITC-conju-
gated donkey anti-guinea pig Ab (1/200, Jackson Immu-
noResearch, West Grove, PA) was used. For granulysin
detection in different LAK subpopulations, the cells were
first labeled with anti human CD Abs (see above) for 20
minutes on ice followed by washing in PBS and fixation.
Fluorescent labeled specimens were examined using a
confocal laser scanning microscope (CLSM SP1, Leica,
Heidelberg, Germany).
Western Blots
LAK-cells or antigen specific T-cells (1–3 × 106 cells) were
lysed in 0.5% Triton X-100, incubated with 0.4 μg/ml
DNAse (Sigma-Aldrich) and subsequently mixed with
SDS-PAGE sample buffer followed by separation on 15%
SDS-PAGE at 200 V for 45 minutes. The proteins were
transferred to an Immobilon-P polyvinylidene fluoride
transfer membrane (Millipore, Billerica, MA) at 100 V for
75 minutes. The membrane was blocked using 1% casein
(Roche, Basel, Switzerland) in TBS-Tween (0.1%) (Sigma-
Aldrich) for 30 minutes. Guinea pig anti-granulysin
(1:1000) and goat anti guinea pig HRP (1:5000, Sigma-
Aldrich) in blocking solution were used for detection. The
signal was visualized using ECL plus western blotting
detection system (Amersham Biosciences, Uppsala, Swe-
den).
Table 1: Primers used in RT-PCR
Primer No. Accesion number Name of primer Sequence
1 NM 006433 NKG5 sense A 5'-GTA TCT GTG GTA AAC CCA-3'
2 NM 006433 NKG5 sense B 5'-GCT CCC TGC CCA TAA AAC AG-3'
3 NM 006433 NKG5 sense C 5'-CAT CTC AGC GGC TGC CC-3'
4 NM 006433 exon 1 end sense 5'-GCT CCT TGC AGC CAT GCT C-3'
5 NM 012483 519 sense 5'-GCC TCA TCG GTG GAT CTG CGT-3'
6 NM 012483 ST antisense (ex2) 5'-GCA GGA AGT CTG CCT TGA AC-3'
7 NM 006433 granulysin antisense 5'-GTG CTC GAG TTA CCT GAG GTC CTC ACA GAT CTG-3'
8 NM 001101 actin sense 5'-TAT ACC ATG GGC CGG GAC CTG ACT GAC TAC-3'
9 NM 001101 actin antisense 5'-GTG CTC GAG GAA CCG CTC ATT GCC AAT GGT G-3'Page 10 of 12
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Total RNA was isolated from LAK- or antigen specific T-
cells by the RNeasy micro kit from Qiagen (Hilden, Ger-
many) according to the manufacturers instructions. First
strand cDNA synthesis was performed using Superscript II
reverse transcriptase and oligo (dT) primers (Invitrogen,
Carlsbad, CA). PCR was performed using Tag DNA
polymerase (Q-Biogene, Irvine, CA) and primers shown
in Table 1. As templates for primer design the different
transcripts found in GenBank or published by Manning et
al. [8] were used. PCR was carried out with RoboCycler
(Stratagene, La Jolla, CA) using the following program:
initial denaturation for 4 minutes at 94°C, followed by 30
cycles of denaturation at 94°C for 45 seconds, annealing
at 58°C for 45 seconds, and extension at 72°C for 45 sec-
onds. Final extension was obtained at 72°C for 8 minutes.
RT-PCR products were subjected to electrophoresis on a
1.5–2% agarose gel containing ethidium bromide and
were visualized under UV light. For semi quantitative
analysis the fluorescent intensity of each band was meas-
ured using ImageJ software [44] and normalized relative
to the intensity of the actin band from the same cDNA.
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